{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:49:31Z","timestamp":1781545771944,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1124\/mol.107.043869","type":"journal-article","created":{"date-parts":[[2007,12,22]],"date-time":"2007-12-22T01:44:56Z","timestamp":1198287896000},"page":"1029-1036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Midazolam Metabolism in Cytochrome P450 3A Knockout Mice Can Be Attributed to Up-Regulated CYP2C Enzymes"],"prefix":"10.1016","volume":"73","author":[{"given":"Robert A.B.","family":"van Waterschoot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius E.","family":"van Herwaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurjen S.","family":"Lagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf W.","family":"Sparidans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Wagenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.M.","family":"van der Kruijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred H.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.043869_REF1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/jpet.104.067819","article-title":"CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products","volume":"310","author":"DeLozier","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043869_REF2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/mol.107.043869_REF3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/00498250701358749","article-title":"Relative roles of CYP2C19 and CYP3A4\/5 in midazolam 1\u2032-hydroxylation","volume":"37","author":"Emoto","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/mol.107.043869_REF4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/00498250050200104","article-title":"Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes","volume":"30","author":"Emoto","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1124\/mol.107.043869_REF5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00008571-199412000-00001","article-title":"Biochemistry and molecular biology of the human CYP2C subfamily","volume":"4","author":"Goldstein","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.107.043869_REF6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1124\/dmd.31.5.548","article-title":"Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam","volume":"31","author":"Granvil","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.107.043869_REF7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.107.043869_REF8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/mol.65.6.1397","article-title":"The constitutive active\/androstane receptor regulates phenytoin induction of Cyp2c29","volume":"65","author":"Jackson","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.043869_REF9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1124\/dmd.106.012005","article-title":"Phenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor","volume":"34","author":"Jackson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.107.043869_REF10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-895X(25)09118-7","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4","volume":"36","author":"Kronbach","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.043869_REF11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","article-title":"Genetic contribution to variable human CYP3A-mediated metabolism","volume":"54","author":"Lamba","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/mol.107.043869_REF12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/mol.107.043869_REF13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1998.0806","article-title":"Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid","volume":"357","author":"Luo","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/mol.107.043869_REF14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.107.043869_REF15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0090-9556(25)06500-6","article-title":"Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes","volume":"23","author":"Newton","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.107.043869_REF16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)35332-7","article-title":"Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms","volume":"292","author":"Perloff","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043869_REF17","first-page":"365","article-title":"Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression","volume":"33","author":"Perloff","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1124\/mol.107.043869_REF18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00008571-199810000-00004","article-title":"Role of human cytochrome P450 3A4 and 3A5 in the metabolism of Taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver","volume":"8","author":"Shou","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.107.043869_REF19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.107.043869_REF20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-3565(24)29299-5","article-title":"Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products","volume":"299","author":"Tsao","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043869_REF21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.105.004721","article-title":"Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4","volume":"33","author":"van Herwaarden","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.107.043869_REF22","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1172\/JCI33435","article-title":"Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism","volume":"117","author":"van Herwaarden","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.107.043869_REF23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/j.1552-4604.1996.tb04251.x","article-title":"Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents","volume":"36","author":"von Moltke","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/mol.107.043869_REF24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/mol.65.5.1148","article-title":"Cloning, expression, and characterization of three new mouse cytochrome P450 enzymes and partial characterization of their fatty acid oxidation activities","volume":"65","author":"Wang","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.043869_REF25","doi-asserted-by":"crossref","first-page":"31686","DOI":"10.1074\/jbc.M504447200","article-title":"Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype","volume":"280","author":"Weng","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043869_REF26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","article-title":"Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.107.043869_REF27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2105-7-85","article-title":"Statistical analysis of real-time PCR data","volume":"7","author":"Yuan","year":"2006","journal-title":"BMC Bioinformatics"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24047965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24047965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.043869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:56:42Z","timestamp":1739959002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24047965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0026895X24047965"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.043869","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midazolam Metabolism in Cytochrome P450 3A Knockout Mice Can Be Attributed to Up-Regulated CYP2C Enzymes","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.043869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}